[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer

• Authors:
  • Fei Ouyang
  • Junling Liu
  • Meng Xia
  • Chuyong Lin
  • Xianqlu Wu
  • Liping Ye
  • Libing Song
  • Jun Li
  • Jing Wang
  • Peng Guo
  • Mian He

• View Affiliations

  
  Affiliations: Department of Gynecology and Obstetrics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China, State Key Laboratory of Oncology in Southern China, Department of Experimental Research,Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510080, P.R. China, Department of biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, P.R. China
• Published online on: March 16, 2021     https://doi.org/10.3892/or.2021.8016
• Article Number: 65

• Copyright : © Ouyang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1

Figure 2